The PAICAP (Preventing Avoidable Infectious Complications by Adjusting Payment) project is funded by the Agency for Healthcare Research and Quality (AHRQ), and is being conducted by researchers at Harvard Pilgrim Health Care Institute and Harvard Medical School.
Our collaborators include leadership at:
- The Association for Professionals in Infection Control and Epidemiology, Inc. (APIC)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare and Medicaid Services (CMS)
- Institute for Healthcare Improvement (IHI)
- Society for Healthcare Epidemiology of America (SHEA)
Grace Lee, MD, MPH
Dr. Lee is Professor of Population Medicine at Harvard Pilgrim Health Care Institute & Harvard Medical School and Director of the Center for Healthcare Research in Pediatrics (CHeRP).
Dr. Lee's research focuses on prevention of healthcare-associated infections, quality metric development, payment policy evaluations, and drug and vaccine safety surveillance. Dr. Lee is principal investigator of an AHRQ-funded grant to evaluate the health and economic impact of the CMS Health Care-Acquired Conditions and Value-Based Purchasing policies, which is called the Preventing Avoidable Infectious Complications by Adjusting Payment (PAICAP) study. She is also principal investigator on an AHRQ-funded grant to develop a national surveillance definition for pediatric ventilator-associated conditions and to identify potential intervention bundles to improve quality of care.
Dr. Lee has served as a member on the Institute of Medicine Committee (IOM) to Review Priorities in the National Vaccine Plan and the IOM Committee on the Ethical and Scientific Issues in Studying the Safety of Approved Drugs. She is currently a member of the AHRQ Healthcare Safety and Quality Improvement Research Study Section and a member of the IOM Board on Population Health and Public Practice.